HEALTH
RADIOTHERAPY AND PROSTATE CANCER It is estimated that prostate in Spain cancer causes up to 7% of cancer deaths in men in Europe.
Localized prostate cancer is radically treated with local therapy, generally surgery and/ or radiation therapy, while advanced/ metastatic prostate cancer is treated with hormone therapy, chemotherapy, and/ or targeted therapies, requiring radiation therapy in some cases to alleviate symptoms or improve. Local control. Radiation therapy is an essential treatment for the multidisciplinary management of this tumor. This treatment has been gaining importance over the years as it presents excellent disease control figures, comparable to surgical treatment1, with the advantage of being a non-invasive treatment. The prevalence of prostate cancer reaches almost 60% in men over 80 years old. Therefore, in this more fragile population of patients, the ideal is to be able to count on a treatment that avoids the patient having to undergo surgery with the risks that this may entail.
34
www.webexpressguide.com
RADIATION THERAPY IS GIVEN WITH CURATIVE INTENT: •
In patients with localized tumor, either low, intermediate or high risk.
•
In higher risk patients. Association with hormonal treatment is required for not only local control but also systemic control of the disease.
•
In patients who after surgery have micro-disease or certain risk factors. The trend now in some of these patients is to actively monitor the possible recurrence / relapse of the disease, and if it occurs, treat the patient with early rescue radiotherapy 2,3
LEAVE YOUR COMMENTS ON OUR BLOG ONLINE AT FOOT OF ARTICLES
